Market Cap | 1.61B | P/E | - | EPS this Y | 86.80% | Ern Qtrly Grth | - |
Income | -351.95M | Forward P/E | -21.55 | EPS next Y | 67.70% | 50D Avg Chg | 32.00% |
Sales | 743.25M | PEG | -0.18 | EPS past 5Y | - | 200D Avg Chg | -13.00% |
Dividend | N/A | Price/Book | 0.47 | EPS next 5Y | 37.00% | 52W High Chg | -54.00% |
Recommedations | 2.70 | Quick Ratio | 0.96 | Shares Outstanding | 806.16M | 52W Low Chg | 58.00% |
Insider Own | 1.27% | ROA | -1.67% | Shares Float | 770.62M | Beta | 2.46 |
Inst Own | 10.53% | ROE | -9.69% | Shares Shorted/Prior | 118.73M/119.31M | Price | 2.37 |
Gross Margin | 29.80% | Profit Margin | -47.35% | Avg. Volume | 19,595,112 | Target Price | 2.36 |
Oper. Margin | -16.54% | Earnings Date | Jul 24 | Volume | 39,084,660 | Change | -0.42% |
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
CIBC | Neutral | Apr 10, 24 |
Roth MKM | Neutral | Sep 1, 23 |
TD Cowen | Outperform | Apr 11, 23 |
Alliance Global Partners | Neutral | Jan 10, 23 |
Bernstein | Market Perform | Nov 2, 22 |
Cantor Fitzgerald | Neutral | Oct 10, 22 |
Barclays | Underweight | Sep 30, 22 |
Cantor Fitzgerald | Neutral | Aug 2, 22 |
Benchmark | Sell | Jul 29, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
FALTISCHEK DENISE M | Chief Strategy Offic.. Chief Strategy Officer | Jan 17 | Buy | 2.05 | 10,000 | 20,500 | 293,269 | 01/18/24 |
Gendel Mitchell | Global General Couns.. Global General Counsel | Jan 16 | Buy | 1.98 | 7,200 | 14,256 | 195,796 | 01/16/24 |
Gendel Mitchell | Global General Couns.. Global General Counsel | Jan 12 | Buy | 1.87 | 5,400 | 10,098 | 188,596 | 01/12/24 |
SIMON IRWIN D | President and CEO President and CEO | Jan 12 | Buy | 1.88 | 53,700 | 100,956 | 2,033,058 | 01/12/24 |
Merton Carl A | Chief Financial Offi.. Chief Financial Officer | Jan 12 | Buy | 1.87 | 20,000 | 37,400 | 20,000 | 01/12/24 |
SIMON IRWIN D | President and CEO President and CEO | Jul 26 | Option | 2.04 | 193,083 | 393,889 | 1,402,326 | 07/28/23 |
Merton Carl A | Chief Financial Offi.. Chief Financial Officer | Jul 26 | Option | 1.93 | 28,513 | 55,030 | 342,804 | 07/28/23 |
Gendel Mitchell | Global General Couns.. Global General Counsel | Jul 26 | Option | 1.93 | 12,166 | 23,480 | 97,455 | 07/28/23 |
FALTISCHEK DENISE M | Chief Strategy Offic.. Chief Strategy Officer | Jul 26 | Option | 1.93 | 25,510 | 49,234 | 198,129 | 07/28/23 |
Looney Thomas P. | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 81,332 | 07/27/23 |
Clanachan David F | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 81,431 | 07/27/23 |
Butts Jodi L. | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 81,431 | 07/27/23 |
Hopkinson David G. | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 77,793 | 07/27/23 |
Herhalt Johann Michael | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 84,481 | 07/27/23 |
Persofsky Renah | Director Director | Jul 26 | Option | 1.93 | 70,621 | 136,299 | 96,891 | 07/27/23 |
Persofsky Renah | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 28,051 | 06/23/23 |
Clanachan David F | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 12,398 | 06/23/23 |
Butts Jodi L. | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 12,398 | 06/23/23 |
Looney Thomas P. | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 10,711 | 06/23/23 |
Hopkinson David G. | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 7,172 | 06/23/23 |
Herhalt Johann Michael | Director Director | Jun 21 | Option | 1.58 | 3,858 | 6,096 | 15,448 | 06/23/23 |
Kennedy Brendan | Director Director | Nov 07 | Sell | 3.7793 | 350,000 | 1,322,755 | 6,224,196 | 11/09/22 |
Kennedy Brendan | Director Director | Sep 06 | Sell | 3.2229 | 350,000 | 1,128,015 | 6,924,196 | 09/08/22 |
Hopkinson David G. | Director Director | Aug 09 | Option | 3.90 | 12,000 | 46,800 | 3,314 | 08/11/22 |
Kennedy Brendan | Director Director | Aug 05 | Sell | 3.9117 | 350,000 | 1,369,095 | 7,274,196 | 08/09/22 |
Kennedy Brendan | Director Director | Jul 05 | Sell | 3.0905 | 350,000 | 1,081,675 | 7,624,196 | 07/07/22 |
Kennedy Brendan | President and CEO President and CEO | Nov 10 | Option | 7.76 | 380,781 | 2,954,861 | 10,245,868 | 11/10/20 |
Kennedy Brendan | President and CEO President and CEO | Nov 10 | Sell | 10.35 | 400,000 | 4,140,000 | 9,845,868 | 11/10/20 |
Kennedy Brendan | President and CEO President and CEO | Nov 06 | Sell | 7.52 | 400,000 | 3,008,000 | 9,865,087 | 11/06/20 |
Kennedy Brendan | President and CEO President and CEO | Sep 25 | Sell | 4.89 | 500,000 | 2,445,000 | 3,577,466 | 09/25/20 |
Kennedy Brendan | President and CEO President and CEO | Sep 24 | Sell | 5.13 | 500,000 | 2,565,000 | 3,577,466 | 09/24/20 |
Kennedy Brendan | President and CEO President and CEO | Sep 23 | Sell | 5.01 | 500,000 | 2,505,000 | 3,577,466 | 09/23/20 |